SCHEMBL7531241

SCHEMBL7531241

CC[Si](CC)(CC)C(F)(F)C(F)(F)F

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.30
NR1H3 Q13133 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27216402 0.77 LMNA (0.33)
SCHEMBL16535722 0.73 NR1H2 (0.30) NR1H2NR1H3
SCHEMBL105887 0.72
SCHEMBL7520321 0.71
Hydrogen Sulfide SCHEMBL27582185 0.69
SCHEMBL18917073 0.65
SCHEMBL6287342 0.63
SCHEMBL4731337 0.63
SCHEMBL4735291 0.61
SCHEMBL31302805 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3750884-B1 NOVEL FLUORINATED UNSATURATED CYCLIC CARBONATE AND PROCESS FOR PRODUCING THE SAME DAIKIN IND LTD (JP) 2022-03-30 EP disclosed
CN-108699049-B Process for preparing benzoxazole compounds 住友化学株式会社 2021-06-25 CN disclosed
US-10246445-B2 Method for producing benzoxazole compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-04-02 US disclosed
US-20190040049-A1 METHOD FOR PRODUCING BENZOXAZOLE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-02-07 US disclosed
EP-3415513-A1 METHOD FOR PRODUCING BENZOXAZOLE COMPOUND Sumitomo Chemical Company Limited (JP) 2018-12-19 EP disclosed
US-20020022734-A1 Polyfluoroalkylsilanes BAYER AKTIENGESELLSCHAFT (DE) 2002-02-21 US disclosed
EP-1170298-A1 Polyfluoroalkylsilanes Bayer Aktiengesellschaft (DE) 2002-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190040049-A1 METHOD FOR PRODUCING BENZOXAZOLE COMPOUND AFF1, AFF4, F11 NR1H2 804/4885NR1H3 522/4885
US-20020022734-A1 Polyfluoroalkylsilanes CCR1, SCO2, CORO1C NR1H2 1209/4885NR1H3 916/4885
US-10246445-B2 Method for producing benzoxazole compound AFF1, AFF4, F11 NR1H2 804/4885NR1H3 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.